Targeting transthyretin amyloidosis in the eye with next-generation stabilizers: AT40 displays potent TTR stabilization in the human vitreous.

Filipa Bezerra Carlos J V SimõesJoão M BeirãoMaria João SaraivaRui M M BritoMaria Rosário Almeida

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2020)

Keyphrases

endothelial cells
induced pluripotent stem cells
pluripotent stem cells
cancer therapy
anti inflammatory